COPD and Chronic Exposure
Learning Objectives
- Describe the pathological changes in emphysema and chronic bronchitis
- Explain the protease-antiprotease imbalance in COPD development
- Analyze the relationship between cumulative exposure and lung function decline
- Interpret the natural history of COPD progression
- Compare reversible and irreversible airway obstruction
COPD: Two Distinct Pathologies
Emphysema
Location: Alveoli and respiratory bronchioles
Pathology: Destruction of alveolar walls, loss of elastic recoil
Mechanism: Protease-antiprotease imbalance
Result: Air trapping, reduced gas exchange surface
Chronic Bronchitis
Location: Bronchi and large airways
Pathology: Mucus hypersecretion, goblet cell hyperplasia
Mechanism: Chronic inflammation from irritant exposure
Result: Productive cough, airway obstruction
The Protease-Antiprotease Hypothesis
Emphysema results from an imbalance between proteolytic enzymes and their inhibitors:
- Neutrophil elastase
- Matrix metalloproteinases (MMPs)
- Cathepsins
- Alpha-1 antitrypsin (AAT)
- Secretory leukocyte protease inhibitor
- Tissue inhibitors of MMPs
Key insight: Oxidative stress from air pollutants inactivates AAT while recruiting neutrophils that release elastase, creating a double hit that accelerates alveolar destruction.
Cumulative Exposure and Lung Function
Fletcher-Peto Curve
The classic model of COPD progression shows FEV1 decline over time:
- Normal: FEV1 declines ~25-30 mL/year after age 25
- Susceptible smokers/exposed: FEV1 declines 50-100 mL/year
- With cessation/intervention: Returns to normal rate of decline (but lost function not regained)
Pack-years concept: Cumulative smoking exposure
Pack-years = (packs per day) x (years smoked)
Similar cumulative exposure metrics apply to occupational and environmental pollutants.
Indoor Air Quality Risk Factors for COPD
| Exposure | Mechanism | Population at Risk |
|---|---|---|
| Biomass fuel smoke | Chronic inflammation, oxidative stress | ~3 billion people globally using solid fuels |
| Secondhand smoke | Same mechanisms as active smoking | Children of smokers, workers in smoking venues |
| Occupational dusts | Particle-induced inflammation, fibrosis | Mining, construction, agriculture workers |
| Indoor NO2 | Oxidative damage to airways | Homes with gas stoves, poor ventilation |
| Chronic PM exposure | Sustained low-grade inflammation | Urban residents, traffic-adjacent housing |
Activity: COPD Risk Analysis
Case Study: A 55-year-old never-smoker presents with progressive dyspnea. History reveals:
- Grew up in rural India cooking over biomass fuel (20 years exposure)
- Worked 15 years in poorly ventilated kitchen with gas stove
- Current FEV1 = 1.8 L (predicted 2.9 L for age/height/sex)
- FEV1/FVC = 0.62
- What is the percent predicted FEV1? What GOLD stage does this represent?
- Identify all potential contributing exposures to her COPD
- How does this case challenge the stereotype that COPD is a "smoker's disease"?
- What indoor air quality interventions might have prevented this outcome?
GOLD Stages: I (mild): FEV1 ≥80%; II (moderate): 50-79%; III (severe): 30-49%; IV (very severe): <30%
Key Takeaway
COPD represents the cumulative damage from chronic pollutant exposure, with both emphysematous destruction of gas exchange surfaces and mucus obstruction of airways. Unlike asthma, the structural changes are largely irreversible. This underscores the importance of primary prevention through improved indoor air quality, particularly in settings where biomass fuels and occupational exposures remain common.